Thermo Fisher Scientific Inc. (NYSE: TMO) had its price target raised by analysts at UBS Group AG from $700.00 to $715.00. They now have a "buy" rating on the stock.
Thermo Fisher Scientific Inc (TMO)
Last thermo fisher scientific inc earnings: 4/22 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.thermofisher.com/investors/investor-overview/default.aspx
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
TMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMO alerts
High impacting Thermo Fisher Scientific Inc news events
Weekly update
A roundup of the hottest topics
TMO
News
- Membrane Chromatography Market Analysis Report 2025-2030, with 3M, Asahi Kasei, Danaher, Merck, Cole-Parmer Instrument, Thermo Fisher Scientific, Sartorius, Air Products, Purilogics and Restek [Yahoo! Finance]Yahoo! Finance
- Complement C4 Antibody Market Research 2025: Growing Focus on Precision Medicine and Targeted Therapies, and Increasing Investment in Immunotherapies and Biologic Drugs - Global Forecast to 2030 [Yahoo! Finance]Yahoo! Finance
- Secondary Neutron Source Materials Market is Projected to Grow USD 568.9 Million with CAGR of 7.3% by 2035 | Fact.MR Report [Yahoo! Finance]Yahoo! Finance
- Ultima Genomics Announces Linda Ramirez as Chief Legal Officer [Yahoo! Finance]Yahoo! Finance
- Global Biobanking Market Projected to Reach USD 160.75 Billion by 2032 | SNS Insider [Yahoo! Finance]Yahoo! Finance
TMO
Earnings
- 1/30/25 - Beat
TMO
Sec Filings
- 3/11/25 - Form 4
- 3/10/25 - Form 144
- 3/6/25 - Form 4
- TMO's page on the SEC website